This inventor holds 7 USPTO granted patents. Top assignees: Neurex Corporation, Elan Pharmaceuticals, Inc.. Active years: 1994-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-2000
Title: Tejinder Singh: Innovator in Analgesia Research
Introduction
Tejinder Singh is a prominent inventor based in Palo Alto, California. He has made significant contributions to the field of analgesia, holding a total of seven patents. His innovative methods focus on enhancing pain relief for both nociceptive and neuropathic pain.
Latest Patents
Among his latest patents is a method for enhancing analgesia. This method involves administering an omega conopeptide that inhibits electrically stimulated contraction of the guinea pig ileum and selectively binds to omega conopeptide MVIIA binding sites in neuronal tissue. Additionally, he has disclosed novel omega conotoxin peptides that are effective in producing analgesia. Another patent details a method of selecting a compound for producing analgesia, which similarly utilizes the properties of omega conopeptides.
Career Highlights
Tejinder Singh has worked with notable companies in the pharmaceutical industry, including Neurex Corporation and Elan Pharmaceuticals, Inc. His work has been instrumental in advancing pain management therapies.
Collaborations
Throughout his career, Tejinder has collaborated with esteemed colleagues such as Alan Justice and Kishor Chandra Gohil. These partnerships have contributed to the development of innovative solutions in pain relief.
Conclusion
Tejinder Singh's work in analgesia research exemplifies the impact of innovation in medical science. His patents and collaborations continue to pave the way for advancements in pain management therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile